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For the last 20 years, knowledge of the physiological role of voltage-dependent potassium 
channels (Kv) in the immune system has grown exponentially. Leukocytes express a limited 
repertoire of Kv channels, which contribute to the membrane potential. These proteins are 
involved in the immune response and are therefore considered good pharmacological targets. 
Although there is a clear consensus about the physiological relevance of Kv1.3, the expression 
and the role of Kv1.5 are controversial. However, recent reports indicate that certain heteromeric 
Kv1.3/Kv1.5 associations may provide insight on Kv1.5. Here, we summarize what is known 
about this issue and highlight the role of Kv1.5 partnership interactions that could be responsible 
for this debate. The Kv1.3/Kv1.5 heterotetrameric composition of the channel and their possible 
differential associations with accessory regulatory proteins warrant further investigation.
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(Kv7), the silent Kv5, Kv6, Kv8, and Kv9 subunits ( modulators), 
and the eag-like channels (Kv10–12). The Kv, KCNQ and eag-like 
K+ channels are typically closed at the resting potential of the excit-
able cells but open when the membrane is depolarized. They are 
involved in the repolarization of the action potential and thus in 
the electrical excitability of nerve and muscle. They also modulate 
activation, proliferation, and differentiation, especially in leuko-
cytes and myocytes (Hille, 2001). Mutations in the genes encoding 
members of these Kv channel subfamilies clearly lead to a number 
of human diseases, such as episodic ataxia, atrial fibrillation, long 
QT syndrome and epilepsy (Lehmann-Horn and Jurkat-Rott, 1999; 
Ashcroft, 2000; Jurkat-Rott et al., 2002, 2010; Gutman et al., 2005; 
Sanguinetti and Tristani-Firouzi, 2006).
Several Kv isoforms have been found in transformed and non-
transformed immune system cells. Although members from the 
Kv1 subfamily (such as Kv1.1, Kv1.2, Kv1.3, Kv1.5, and Kv1.6) have 
been detected in primary lymphocytes and macrophages (Pyo 
et al., 1997; Liu et al., 2002; Vicente et al., 2003), eag-like K+ chan-
nels (Kv10.1 and Kv11.1) are found in lymphoblastic leukemias 
and during neoplastic growth (Pillozzi et al., 2002; Smith et al., 
2002). Thus, although Kv10.1 (h-eag) is not present in any primary 
leukemic cells or non-transformed lymphocytes, the channel is up- 
regulated in myelodysplastic syndromes, chronic myeloid leukemia 
and acute myeloid leukemias (Agarwal et al., 2010). In addition, 
Kv11.1 (h-erg) is up-regulated in cancer cells but has no correlation 
with any growth phenotype because it is not elevated in proliferat-
ing non-cancerous lymphocytes (Smith et al., 2002).
Kv1.3 is considered the major type responsible for the voltage-
 dependent K+ currents in these cells (Rangaraju et al., 2009). 
Although Kv1.3 channels contribute to the resting membrane 
potential in immune system cells (Cahalan et al., 1985; Beeton 
and Chandy, 2005; Cahalan and Chandy, 2009; Krummel and 
Cahalan, 2010), anion currents compensate in Kv1.3 knock-out 
K+ channels in the immune system
The immune response is modulated by membrane transduction of 
extracellular signals. Many interactions occur via the regulation of 
transmembrane ion fluxes, which govern several signal transduc-
tion pathways (Eder, 1998). Thus, immune system cells change 
their membrane electrophysiological properties depending on their 
functional state. Changes in membrane potential are among the 
earliest events occurring upon stimulation or immunosuppression, 
and ion channels underlie the Ca2+ signal involved in leukocyte 
responses. In this context, potassium channels indirectly deter-
mine the driving force for Ca2+ entry. Several types of K+ channels 
determine the membrane potential, thereby playing a crucial role 
in cellular excitability. Despite the importance of K+ channels in 
the maintenance of electrogenic driving force for Ca2+ channels, 
leukocytes express a limited repertoire (Cahalan and Chandy, 1997, 
2009; Panyi, et al., 2004). Thus, only the inwardly-rectifying K
ir
2.1, 
Ca2+-dependent K+ channels (K
Ca
), and some voltage-dependent 
K+ channels (Kv) have been detected in leukocytes (Beeton and 
Chandy, 2005).
Voltage-dependent K+ channels
The voltage-dependent K+ channel (Kv) superfamily is the most 
diverse, numerous, and ubiquitous class of K+ channel groups. Kv 
channels contribute to the resting membrane potential and con-
trol action potentials of excitable cells (Hille, 2001). In addition, 
they are involved in the activation and proliferation of leukocytes. 
Accumulating evidence indicates that Kv channels play a pivotal 
role in the modulation of immune responses (Beeton and Chandy, 
2005; Cahalan and Chandy, 2009).
Kv channels possess six transmembrane domains and may be fur-
ther subdivided into twelve conserved gene subfamilies. These sub-
families comprise the voltage-dependent channels Kv1–4 (Shaker, 
Shab, Shaw, Shal-like subunits), the so-called KCNQ  channels 
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 addition, Kv1.3 has a number of specific blockers. Thus, scorpion 
toxins, such as charybdotoxin (Leiurus quinquestriatus hebraeus) 
and margatoxin (Centruroides margaritatus) as well as sea anemone 
peptides, such as Shk (Stichodactyla helianthus) and their deriva-
tives, have proven to be highly effective. Furthermore, there are 
several Kv1.3 chemical inhibitors, such as the potent 5-(4-phenyl-
butoxy) psoralen (Psora-4) (Vennekamp et al., 2004)1.
Kv1.5 (KCNA5) shows characteristics typical of voltage-gated K+ 
channels in cardiac myocytes. It was cloned from rat brain (Swanson 
et al., 1990), although the distribution is more ubiquitous than previ-
ously thought (Bielanska et al., 2009). Kv1.5 contributes to the ultra-
rapid activating K+ current in heart (IK
ur
), but it is also involved in 
myoblast proliferation and cell volume control (Felipe et al., 1993; 
Villalonga et al., 2008). Kv1.5 conductance is 8 pS, and the V
h
 for 
activation is approximately 14 mV. In addition, Kv1.5 inactivates 
very slowly (τ > 5 s) and lacks cumulative inactivation. Kv1.5, which 
is highly insensitive to Kv1.3 blockers, has no known specific phar-
macology. However, this is currently under intensive investigation. 
Current research indicates that Kv1.5, similar to Kv1.3, is inhibited 
by 4-AP, TEA, and some new chemicals, such as S0100176 (from 
Sanofi-Aventis) or diphenyl phosphine oxide-1 (DPO-1) (Decher 
et al., 2004; Villalonga et al., 2008; Du et al., 2010)2.
Kv1.5 in the immune system
Pioneer work conducted during the 1970s by Gallin and coworkers 
described the first K+ currents in peritoneal macrophages (Gallin 
et al., 1975; Gallin and Gallin, 1977; Gallin and Livengood, 1980). 
Later, this K+ outward conductance was characterized in both lym-
phocytes and macrophages (Gallin, 1981, 1984; Ypey and Clapham, 
1984; Decoursey et al., 1987). Although delayed rectifier K+ currents 
are similar in both cell types, Kv1.5 was soon detected in microglia 
(brain macrophages) (Pyo et al., 1997; Jou et al., 1998). These early 
works suggested that Kv1.5 plays an important role in the immune 
system. However, elicited currents showed certain C-type inactiva-
tion, which is absent in Kv1.5. In addition, Kv1.3 blockers, such as 
Charybdotoxin, were used to pharmacologically characterize the 
current in macrophages (Kim et al., 1996). However, this appar-
ent discrepancy could be explained by the cellular models analyzed 
(Table 1). These works mostly analyzed peritoneal elicited macro-
phages, and under these experimental conditions, cells were isolated 
upon intraperitoneal injection (Gallin and Livengood, 1980; Ypey 
and Clapham, 1984). Currently, we know that Kv1.3 and Kv1.5 are 
subject to differential regulation (Vicente et al., 2006; Villalonga et al., 
2010a). Under activation conditions, unlike Kv1.5, Kv1.3 is selectively 
activated. Any study in activated cells would underestimate the Kv1.5-
dependent component of the outward K+ current. Later works from 
Eder and coworkers demonstrated that, unlike T-cells, resting bone 
marrow-derived macrophages express less inactivating outward K+ 
currents, which are selectively induced by specific growth factors 
(Eder and Fischer, 1997). These more recent reports suggested that 
notable differences exist between T-lymphocytes and macrophages. 
In 2003, we published a complete biophysical, pharmacological and 
molecular characterization of the Kv1 channels present in macro-
phages (Vicente et al., 2003). Although pharmacological experiments 
mice (Koni et al., 2003). However, this protein plays a critical role 
during activation and proliferation of leukocytes, and several stud-
ies point to this channel as an excellent target for immunomodula-
tion (Beeton and Chandy, 2005; Rangaraju et al., 2009). Kv1.3 is 
abundantly expressed in T-effector memory lymphocytes. These 
T-cells are key mediators in autoimmune inflammatory diseases, 
such as multiple sclerosis, rheumatoid arthritis, psoriasis, and type 
I diabetes, and Kv1.3-based therapies are effective in experimen-
tal models (Beeton and Chandy, 2005; Rangaraju et al., 2009). 
Although Kv1.3 activity determines the level of leukocyte activa-
tion, this may be conditioned by the presence of other Kv1 isoforms 
and their association with accessory subunits (Beeton and Chandy, 
2005; Vicente et al., 2005a).
Lymphocytes express several Kv currents (n-, n′- and l-type chan-
nels). While the type n channel is the most commonly observed K+ 
channel in normal T-lymphocytes, the subtype l has a larger single-
channel conductance, and the n′ channel has biophysical and phar-
macological properties similar to those of the n channel but is more 
resistant to block by tetraethylammonium (TEA) (Grissmer et al., 
1992). Whereas Kv1.3 is associated with the n-type channel and Kv3.1 
seems to account for the l-type, the protein responsible for the n′-type 
is uncertain (Grissmer et al., 1992; Cahalan and Chandy, 1997). In 
addition, other channel proteins have been described in immune sys-
tem cells. Kv1.1 is present in CD4−CD8− thymocytes, and the pres-
ence of Kv1.1, Kv1.2, and Kv1.6 has been documented in naïve CD4+ 
lymphocytes (Liu et al., 2002). In addition, several regulatory subunits 
may tune Kv currents resembling different entities. Thus, classical Kvβ 
subunits are present in lymphocytes and macrophages (Autieri et al., 
1997; Vicente et al., 2005a). Furthermore, other types of modulatory 
subunits, such as KCNEs, are also present in leukocytes (Sole et al., 
2009; Sole and Felipe, 2010). For example, KCNE1 was cloned from 
T-cells (Attali et al., 1992), and KCNE4 is expressed in macrophages 
(Sole et al., 2009). In this scenario deciphering the composition of 
channel structures that include channel subunits and regulatory pro-
teins (channelosome) in leukocytes is worth of effort.
In addition, pharmacological studies in lymphocytes as well as 
in macrophages have demonstrated that the blockage of the K+ 
outward current by K+ channel-blockers, such as charybdotoxin, 
TEA and 4-Aminopyridine (4-AP) reveals other components. 
These components have more depolarized thresholds for activa-
tion, absence of inactivation under sustained depolarized pulses 
and negligible cumulative inactivation (Ypey and Clapham, 1984; 
Decoursey et al., 1987; Verheugen and Korn, 1997). Although the 
presence of Kv3.1 could somehow explain these features, Kv1.5 may 
be an alternative candidate (Grissmer et al., 1992; Verheugen and 
Korn, 1997; Vicente et al., 2003, 2005a).
differential features of Kv1.3 and Kv1.5
Kv1.3, the major leukocytic Kv channel, and Kv1.5 show character-
istic features that clearly differentiate both proteins.
Kv1.3 (KCNA3) is a voltage-gated K+ channel that was cloned 
in brain, but it is highly present in lymphocytes and olfactory bulb 
(Stuhmer et al., 1989). However, recent works have demonstrated 
that it is more widely expressed, especially in skeletal muscle and 
epithelia (Bielanska et al., 2009). Kv1.3 exhibits marked C-type 
and cumulative inactivation. The single-channel conductance of 
Kv1.3 is about 13 pS, and the V
h
 for activation is around −35 mV. In 
1http://www.iuphar-db.org/iuphar-ic/KV/KV13.pdf
2http://www.iuphar-db.org/iuphar-ic/KV/KV15.pdf
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Under such conditions, Kv1.5 would be inefficient because it has 
a depolarized V
1/2
 for activation (14 mV) (Table 1). Furthermore, 
the pharmacology of Kv1.3 blockers indicates that whereas Kv1.3 
may exist as homotetramers, Kv1.5 never forms functional homo-
meric channels (Villalonga et al., 2007, 2010a). In this scenario, 
functional complexes formed by high Kv1.3/Kv1.5 ratios would 
exhibit biophysical and pharmacological characteristics that 
closely resemble Kv1.3 homomers (Vicente et al., 2006, 2008). 
However, functional complexes generated by low Kv1.3/Kv1.5 
ratios would exhibit biophysical characteristics closely related 
to Kv1.5, but the pharmacology of the channel, although lim-
ited, would be still sensitive to Kv1.3 blockers (Vicente et al., 
2006, 2008).
Different hetero-oligomeric ratios trigger a plethora of func-
tional complexes with different characteristics (Figure 1). The 
Kv1.3/Kv1.5 ratio, which would resemble Kv1.3-like to Kv1.5-like 
homomeric channels, would have important physiological conse-
quences. In addition, these ratios may vary upon the physiological 
situation. Recent reports from our laboratory explore this issue 
(Vicente et al., 2006; Villalonga et al., 2007, 2010a). While LPS 
(lipopolysaccharide) or TNF-α-activated macrophages increase 
the number of Kv1.3 subunits at the complex, dexamethasone, 
a potent glucocorticoid which abrogates the immune response, 
down-regulates Kv1.3 and raises the Kv1.5 units in the heteromeric 
channel (Villalonga et al., 2010a). In this situation, biophysical, 
and pharmacological characteristics resemble Kv1.5 (Figure 1). 
Therefore, the pharmacology of Kv1.3/Kv1.5 hybrid channels, 
with high Kv1.5 ratio, is more resistant to Kv1.3 blockers, and 
suggested that Kv1.3 is predominant, Kv1.5 is also present in the 
myeloid lineage. Furthermore, cell activation selectively increases 
Kv1.3 activity, and these phenotypical changes are under tight tran-
scriptional, translational, and post-translational controls in macro-
phages, which may implicate hetero-oligomeric associations in the 
macrophage channelosome (Vicente et al., 2006).
During the same time frame, Mackenzie et al. (2003) described 
that human alveolar macrophages only express Kv1.3, with no other 
Kv1 isoforms. However, because MgTx (1 nM) does not abrogate Fc 
receptor-mediated phagocytosis, the authors suggested that although 
Kv1.3 sets the resting membrane potential, it is not required for 
phagocytosis. The debate intensified when Park et al. (2006), using 
a similar experimental model, concluded that Kv1.5, but not Kv1.3, 
plays a pivotal role in human alveolar macrophages.
A common feature of all these studies is the sensitivity of K+ 
currents to some blockers such as MgTx, 4-AP, TEA, or Shk-Dap22. 
Several works also tried to abrogate K+ currents by incubating with 
antisense oligonucleotides and adenovirus, and differing results 
have indicated possible roles for both proteins in the immune 
physiology (Chung et al., 2001; Mullen et al., 2006; Pannasch et al., 
2006). Therefore, for the first time, a new putative role for the Kv1.5 
channel in the immune system was highlighted in a comprehensive 
review (Judge et al., 2006). In 2006, the field took an important 
step forward. Several laboratories identified shared expression of 
both Kv1.3 and Kv1.5 proteins in the myeloid lineage (Mullen et al., 
2006; Pannasch et al., 2006; Park et al., 2006; Vicente et al., 2006). 
Thus, both channels were found to modulate distinct functions in 
microglia, dendritic cells, and macrophages. However, the precise 
mechanism was still under debate (Fordyce et al., 2005). The initial 
evidence of heterotetrameric associations was suggested 1 year pre-
viously (Vicente et al., 2005b). These reports led many laboratories 
to the hypothesis that Kv1.3 and Kv1.5 could interact, forming a 
heterotetrameric functional channel.
Subsequent work performed in our laboratory unequivocally 
demonstrated that both proteins heteromerize in macrophages 
(Vicente et al., 2006; Villalonga et al., 2007; Villalonga et al., 2010a). 
Specifically, our results revealed that the functional heteromeric 
complex shows different sensitivity to Kv1.3 blockers and exhibits 
biophysical features accounted for by a variable tetrameric protein 
ratio.
physiological role of the heterotetrameric channel 
in the immune system
With few exceptions, most laboratories find that microglia, macro-
phages, and dendritic cells, all from the myeloid lineage, coexpress 
Kv1.5 and Kv1.3. In addition, many studies demonstrated that both 
proteins are involved in leukocyte physiology in some way. The 
question of to what extent Kv1.5 controls the immune function 
remains. Arguments both against and in favor of a crucial role for 
Kv1.5 in the immune system have been presented. However, the 
answer could be the variable composition of a tetramer (Vicente 
et al., 2006; Villalonga et al., 2007, 2010a) (Figure 1). Similar argu-
ments are valid for many K+ channels in the cardiovascular and 
nervous systems (Roden et al., 2002; Vacher et al., 2008).
Membrane potential of leukocytes ranges from −30 to −60 mV 
(Rink et al., 1980; Mello de Queiroz et al., 2008). Kv1.3 has a V
1/2
 
for activation of −35 mV, and this value is in a  physiological range. 
FIguRE 1 | Major Kv1.3/Kv1.5 heterotetrameric forms in mononuclear 
phagocytes. Cells express Kv1.3 and Kv1.5. Since most studies demonstrate 
that Kv1.3 blockers abolish Kv currents, Kv1.5 does not form homomeric 
complexes. However, molecular, pharmacological, and biophysical data 
indicates that cells coexpress Kv1.5 and Kv1.3. The initial ratio between Kv1.3 
and Kv1.5 may vary among different cell types. Upon activation by pro-
inflammatory agents (e.g., LPS or TNF-α) cells increase the number of Kv1.3 
subunits at the complex (↑Kv1.3/Kv1.5). However, anti-inflammatory insults 
(e.g., dexamethasone) generate immunosuppression that decreases Kv1.3, 
which generates Kv1.5-predominant heteromeric channels (↓Kv1.3/Kv1.5). 
Different Kv1.3/Kv1.5 molecular ratios are responsible for distinct biophysical 
and pharmacological properties that lead to diverse functional consequences 
and disperse results.
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this channel. Later, a ternary complex formed by caveolin 3, 
SAP97 ( Synapse-associated protein 97) and Kv1.5 was discov-
ered (Folco et al., 2004). However, evidence indicates that the 
channel localization is more complex than previously thought 
(Martinez-Marmol et al., 2008). The coexpression of caveolin 
(Cav1 and Cav3) and Kv1.5 triggers their association and places 
the channel within lipid rafts (McEwen et al., 2008). However, 
in native tissues, the presence of Kv1.5 in rafts is under debate 
(Eldstrom et al., 2006; Martinez-Marmol et al., 2008). Although 
heterologously expressed Kv1.5 is located in raft microdomains 
in HEK 293 and fibroblasts cells, the channel is not present in 
rafts in cardiomyoblasts, skeletal muscle myoblasts and mac-
rophages (Martens et al., 2001; Eldstrom et al., 2006; Vicente 
et al., 2008). However, upon activation, high Kv1.3/Kv1.5 ratios in 
macrophage channels partially relocate Kv1.5 in rafts (Martinez-
Marmol et al., 2008). In this context, experimental evidence has 
suggested that the putative association of Kv1.5 with Kv1.3 and 
other partnership interactions with accessory proteins may influ-
ence the channelosome surface expression (Figure 2). In fact, 
different Kv1.3/Kv1.5 ratios influence oligomeric channel traf-
ficking and locate functional heteromeric channels in different 
surface microdomains (Vicente et al., 2008).
Kv1.5 regulatory partnership interactions
Although the Kv1.3/Kv1.5 association could be considered as a main 
regulatory mechanism that controls leukocyte excitability (at least 
in myeloid cells), alternative associations to accessory proteins must 
be contemplated. In this context, Kv1.5 may interact with most 
proteins that have been extensively studied with Kv1.3. For example, 
similar to Kv1.3, Kv1.5 has a PDZ domain at the C-terminus that 
more importantly, the threshold for activation of heteromeric 
channels depolarizes (Vicente et al., 2006). At physiological 
membrane potentials (−30 to −60 mV), Kv1.3/Kv1.5 (low Kv1.3 
ratio) channel activity is impaired. Because negative potentials, 
contributed by Kv1.3, should open CRAC (Ca2+ release-activated 
Ca2+) channels leading to further activating signals (Cahalan and 
Chandy, 2009), this scenario triggers immunosuppression and 
anti-inflammatory effects (Villalonga et al., 2010a,b). A similar 
situation has been described in B-lymphocytes where a + 25 mV 
shift in the membrane potential negatively modulates the capa-
bility of B-cell producing antibodies (Freedman et al., 1992). 
Analogous results were obtained when two different macrophage 
cell lines were studied, such that macrophages that had higher 
Kv1.3/Kv1.5 ratios were more sensitive to Kv1.3-blockers, indi-
cating that the physiological response is under Kv1.3 antagonist 
control (Villalonga et al., 2007). Similar phenotypical changes 
are produced during human dendritic cell maturation, which 
suggest that this is a general feature of Kv1.3/Kv1.5 expressing 
leukocytes (Zsiros et al., 2009).
Kv1.5 localization in the immune system
Another unresolved but important issue concerns to what extent 
the Kv1.3/Kv1.5 heterotetramerization affects the channelosome 
localization. Kv1.3 forms part of a macromolecular complex 
associated with the TCR (T-cell receptor) in lymphocytes. Kv1.3, 
together with K
Ca
3.1, generates the membrane potential that acti-
vates CRAC (Ca2+-release-activated Ca2+) channel upon TCR acti-
vation (Panyi et al., 2004; Cahalan and Chandy, 2009). This event 
occurs within the so-called immunological synapse (IS) between 
the T-cell and the antigen presenting cell (Panyi et al., 2003, 2004; 
Toth et al., 2009; Krummel and Cahalan, 2010; Varga et al., 2010). 
The association of Kv1.3 and the TCR/CD3 receptor has been 
documented by FRET (fluorescence resonance energy transfer). In 
this vein, molecular interactions between Kv1.3 and β1-integrin, 
and SAP-97 (synapse-associated protein 97) and Kvβ2 regulatory 
subunits has been also documented (Panyi et al., 2004, Cahalan 
and Chandy, 2009). This macromolecular complex is located in 
lipid rafts (Toth et al., 2009). Lipid rafts are microdomain plat-
forms, rich in sphingolipids and cholesterol, where many signaling 
molecules and their targets converge. Many studies demonstrate 
that Kv1.3 channelosome concentrates in the T-cell IS, within 
lipid rafts, and the raft disruption impairs the immune response 
(Nicolaou et al., 2007; Pottosin et al., 2007; Toth et al., 2009). In 
addition, immobilizing Kv1.3 channels at the IS increases the Ca2+ 
signaling, raising the downstream signaling transduction pathways 
(Nicolaou et al., 2007).
Macrophages and dendritic cells are professional antigen 
presenting cells, and share the expression of Kv1.3 and Kv1.5 
(Vicente et al., 2003; Villalonga et al., 2007; Zsiros et al., 2009). 
There is no information about the specific localization of the 
channelosome in these cells within the IS. However, it is tempt-
ing to speculate that some molecular aggregation similar to that 
observed in T-cells may exist. In this context, Kv1.5 localization 
in lipid raft is under debate (Martinez-Marmol et al., 2008). 
Ten years ago, Kv1.5 was the first ion channel detected in lipid 
rafts and caveolae (Martens et al., 2001). However, authors 
argued against a physical  interaction between caveolins and 
FIguRE 2 | Distinct voltage-dependent K+ channel compositions trigger 
different membrane surface microdomain targeting. While Kv1.3 efficiently 
targets to lipid rafts (a), Kv1.5 targeting depends on partnership interactions. 
Kv1.5 localizes in rafts when overexpressed in heterologous systems (b). 
However, the channel does not target to these microdomains in native 
tissues, probably due to the presence of interacting subunits yet to determine 
(e.g., Kvβ2.1) (c). In leukocytes, heterotetrameric channels with high Kv1.3/
Kv1.5 (↑Kv1.3/Kv1.5) ratio localize in rafts (d). On the contrary, low Kv1.3/Kv1.5 
ratios (↓Kv1.3/Kv1.5) impair raft localization of the channels (e). Macrophage 
activation, which triggers a selective increase of Kv1.3 subunits, generates 
high Kv1.3/Kv1.5 ratio heteromers which target back to lipid rafts (f).
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conclusion
Although the voltage-dependent Kv1.3 channel is essential for the 
immune cell physiology increasing evidence indicate that Kv1.5 plays 
an important role fine tuning the immune response. Pharmacological 
and biophysical reports argue against homomeric Kv1.5 complexes, 
but hetero-oligomeric associations with Kv1.3 increase the possi-
bilities for Kv channels in leukocytes. The identification of multiple 
heterotetrameric conformations and their membrane surface locali-
zation may bring to light a better use for K+ channels as pharmaco-
logical targets in autoimmune diseases. Furthermore, in this scenario, 
the multiple regulatory subunit association to homo- and hetero-
meric channels in the immune system is revealed as an important 
mechanism for further study to enhance the current understanding 
of the role of Kv1.5 in the immune physiology.
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These interactions are known to modulate the surface expression 
of several K+ channels, such as Kv4.2 (Shibata et al., 2003). Other 
possible candidates are the classical Kvβ subunits (Martens et al., 
1999). These ancillary subunits, which are tightly modulated upon 
proliferation and the way of activation in macrophages, regulate 
Kv1.3 and Kv1.5 activity and may also control the channel expres-
sion at the membrane surface (Martens et al., 1999; Vicente et al., 
2005a). In fact, the presence of the Kvβ2.1 subunit impairs the 
location of Kv1.5 in rafts, and this has been proposed to be the 
mechanism of how Kv1.5 colocalizes with caveolin in heterolo-
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